OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. A variety of strategies have been employed enhance antibody titer, such as process parameter optimization, cell line development, and adoption of perfusion systems. Fine-tuning culture conditi